Konstantina Stankovic, M.D., Ph.D., FACS
|Specialty:||Otology and Neurotology|
243 Charles Street
Boston, MA 02114
|Office Hours:||Tues. 8:30 a.m. - 5 p.m.|
|Board Certification:||Otolaryngology-Head and Neck Surgery
|Graduate School||MIT and Harvard/MIT Division of Health Sciences and Technology|
|MD||Harvard Medical School and Harvard/MIT Division of Health Sciences and Technology|
|Internship||Harvard Medical School (General Surgery)|
|Residency||Harvard Medical School (Otolaryngology)|
|Fellowship||Massachusetts Eye and Ear Infirmary (Neurotology and Skull Base Surgery)|
|Teaching Affiliation||Assistant Professor of Otology and Laryngology, Harvard Medical School|
Dr. Stankovic is a board-certified ear and skull base surgeon and a Ph.D.-trained auditory neuroscientist. Her medical education includes a medical degree from Harvard (Magna Cum Laude), Internship in General Surgery at the Massachusetts General Hospital, Residency in Otolaryngology - Head and Neck surgery at Harvard and Massachusetts Eye and Ear, and Fellowship in Neurotology - Skull Base Surgery at Harvard and Mass. Eye and Ear.
She has received numerous awards, including the Association of M.I.T. Alumnae award for the highest degree of academic excellence and professional promise, the Henry Asbury Christian Award for outstanding performance in research and scholarly activitiesat Harvard Medical School, the Howard Hughes Medical Institute postdoctoral research fellowship, the Burt Evans young investigator award from the National Organization for Hearing Research, and Harvard/MIT Thomas A. McMahon Mentoring Award. She serves on the Long Range Planning Committee of the Association for Research in Otolaryngology,and on the editorial board of Otology and Neurotology. She is president of the American Auditory Society
Concurrent with her clinical activities, she directs a basic science laboratory that focuses on hearing and hearing restoration. The approach is interdisciplinary, combining tools of systems neuroscience with optics, ultra low power electronics, molecular biology and and genomics to improve diagnostics, prognostics and therapeutics for deafness. Recent research highlights include optical imaging of cells inside the inner ear without contrast dyes, development of a prototype chip for a fully implantable cochlear implant, energy extraction from the inner ear to run electronics, and discovery that aspirin intake may prevent growth of intracranial tumors (vestibular schwannomas/ acoustic neuromas) that cause hearing loss. Her research has been published in leading journals and has also received international media coverage, including by National Public Radio, ABS news, CBS news, Wall Street Journal, Los Angeles Times, Canadian Broadcasting Corporation, Danish Broadcasting Corporation, New England Cable News.
Her clinical and research work drives and reinforces one another. Her involvement in cutting-edge research gives her patients the opportunity to participate in clinical trials that could lead to breakthroughs in addressing the problems of participating patients, while advancing the knowledge frontier of the auditory field.
Otology/Neurotology, including hearing loss in adults and children, cochlear implants and other implantable hearing devices, acoustic neuromas (vestibular schwannomas), otosclerosis, cholesteatoma, tumors of temporal bone.